SCHEMBL7327849

SCHEMBL7327849

CCCN(CCC)C1CCc2c(cccc2N(C)C(=O)c2ccccc2)C1

nearest known ligand 0.59

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 8/20 0.59
DRD3 P35462 5/20 0.59
DRD4 P21917 4/20 0.59
DRD1 P21728 4/20 0.59
HTR1A P08908 3/20 0.59
HTR7 P34969 3/20 0.59
DRD5 P21918 1/20 0.59
ADRB2 P07550 1/20 0.59
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2D6 P10635 1/20 0.56
TSHR P16473 1/20 0.56
NFKB1 P19838 1/20 0.56
THPO P40225 1/20 0.56
LMNA P02545 1/20 0.55
PMP22 Q01453 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7335087 0.86 DRD2 (0.64) DRD2DRD3DRD4DRD1HTR1A
SCHEMBL7327260 0.80 DRD2 (0.64) DRD2DRD3DRD4DRD1HTR1A
Hydrochloric Acid SCHEMBL7334103 0.79 DRD2 (0.66) DRD2DRD3DRD4DRD1HTR1A
SCHEMBL7331703 0.79 DRD2 (0.61) DRD2DRD3DRD4DRD1HTR1A
SCHEMBL7334180 0.79 DRD2 (0.67) DRD2DRD3DRD4DRD1HTR1A
SCHEMBL7328609 0.79 DRD2 (0.62) DRD2DRD3DRD4DRD1HTR1A
SCHEMBL7328876 0.78 DRD2 (0.59) DRD2DRD3DRD4DRD1HTR1A
SCHEMBL7331288 0.77 DRD2 (0.61) DRD2DRD3DRD4DRD1HTR1A
Hydrochloric Acid SCHEMBL7336566 0.77 DRD2 (0.66) DRD2DRD3DRD4DRD1HTR1A
SCHEMBL7335448 0.76 DRD2 (0.68) DRD2DRD3DRD4DRD1HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5196454-A METHOD OF TREATING DISORDERS OF THE DOPAMINERGIC SYSTEMS USING 2,5-DIAMINOTETRALINES BOEHRINGER INGELHEIM KG (DE) 1993-03-23 US disclosed
EP-0402923-A2 2,5-Diaminotetralines, process for their preparation and their use as medicine BOEHRINGER INGELHEIM KG (DE) 1990-12-19 EP disclosed